Preclinical models.
Published literature.
The comparisons below are illustrative summaries of published in-vitro and preclinical research literature for the ENOS compound classes shown. Reference material for qualified researchers — not use protocols, not recommendations, not descriptions of human outcomes.
Not for human consumption, diagnosis, or treatment. Purchaser must be 18+.
GHRH / GHRP Class — Preclinical Model Illustration
Illustrative comparison summarizing published preclinical literature on the CJC-1295 + Ipamorelin research combination and the 5-Amino-1MQ NNMT-inhibitor class. Reference material only — not a use protocol.
Represents published in-vitro and preclinical model observations reported in the peer-reviewed research literature.
Cytoprotective Peptide Class — Preclinical Model Illustration
Illustrative comparison summarizing published preclinical literature on the BPC-157 and TB-500 research pair in tissue-repair signaling models. Reference material only — not a use protocol.
Represents published preclinical model observations from the peer-reviewed research literature.
NAD+ / Copper-Peptide Class — Preclinical Model Illustration
Illustrative comparison summarizing published preclinical literature on NAD+ precursor chemistry, the GHK-Cu copper(II) tripeptide complex, and the MOTS-c mitochondrial-derived peptide. Reference material only — not a use protocol.
Represents published preclinical model observations from the peer-reviewed research literature.
Ready to design your own study?
Every ENOS compound ships with a batch-matched COA and cold-chain shipping. Start with the same verified vials our researchers used.